{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:10:51Z","timestamp":1761181851518,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP\/2021\/45"],"award-info":[{"award-number":["RSP\/2021\/45"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.sjbs.2021.12.044","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T11:31:08Z","timestamp":1640345468000},"page":"2613-2619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emergence of resistance against direct acting antivirals in chronic HCV patients: A real-world study"],"prefix":"10.1016","volume":"29","author":[{"given":"Abdul","family":"Majid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumbal","family":"Haleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najib","family":"ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riaz","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeela","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidayat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sohaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sjbs.2021.12.044_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-016-2575-8","article-title":"A method for near full-length amplification and sequencing for six hepatitis C virus genotypes","volume":"17","author":"Bull","year":"2016","journal-title":"BMC Genom."},{"issue":"7","key":"10.1016\/j.sjbs.2021.12.044_b0010","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/01431160701758707","article-title":"Technical report: standardization of the Athens Dobson spectrophotometer versus reference Dobson spectrophotometer 064","volume":"29","author":"Christodoulakis","year":"2008","journal-title":"Int. J. Rem Sens."},{"issue":"3","key":"10.1016\/j.sjbs.2021.12.044_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJMe1113272","article-title":"A watershed moment in the treatment of hepatitis C","volume":"366","author":"Chung","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.sjbs.2021.12.044_b0020","doi-asserted-by":"crossref","unstructured":"Dalgard, O., Weiland, O., Noraberg, G., Karlsen, L., Heggelund, L., F\u00e4rkkil\u00e2, M., Balslev, U., Belard, E., \u00d8vrehus, A., Skalsh\u00f8i, K.M., 2017. Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-a Scandinavian real-life study. PLoS ONE. 12(7), e0179764.","DOI":"10.1371\/journal.pone.0179764"},{"issue":"27","key":"10.1016\/j.sjbs.2021.12.044_b0025","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.sjbs.2021.12.044_b0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s40506-017-0124-x","article-title":"Treatment of hepatitis C virus (HCV) genotype 1 disease","volume":"9","author":"Forde","year":"2017","journal-title":"Curr. Treat. Opt. Infect. Diseases"},{"issue":"4","key":"10.1016\/j.sjbs.2021.12.044_b0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.sjbs.2021.12.044_b0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.sjbs.2021.12.044_b0045","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.sjbs.2021.12.044_b0050","doi-asserted-by":"crossref","unstructured":"Jamil, Z., Waheed, Y., Malik, M., Durrani, A.A., 2018. Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study. PeerJ. 6, e4853.","DOI":"10.7717\/peerj.4853"},{"issue":"3","key":"10.1016\/j.sjbs.2021.12.044_b0055","first-page":"e86428","article-title":"Molecular epidemiology of hepatitis C virus genotypes among chronically infected patients in Pakistan","volume":"12","author":"Khan","year":"2019","journal-title":"Jundishapur J. Microbiol."},{"issue":"20","key":"10.1016\/j.sjbs.2021.12.044_b0060","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.sjbs.2021.12.044_b0065","doi-asserted-by":"crossref","first-page":"e6830","DOI":"10.1097\/MD.0000000000006830","article-title":"Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"issue":"1379","key":"10.1016\/j.sjbs.2021.12.044_b0070","article-title":"Efficacy and safety of generic sofosbuvir plus daclatasvir and sofosbuvir\/velpatasvir in HCV genotype 3-infected patients: real-world outcomes from Pakistan","volume":"11","author":"Mushtaq","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.sjbs.2021.12.044_b0075","first-page":"2367","article-title":"Changing the face of hepatitis C management-the design and development of sofosbuvir","volume":"9","author":"Noell","year":"2015","journal-title":"Drug Design Dev. Ther."},{"issue":"4","key":"10.1016\/j.sjbs.2021.12.044_b0080","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/AAC.02776-15","article-title":"Comprehensive screening for naturally occurring hepatitis C virus resistance to direct-acting antivirals in the NS3, NS5A, and NS5B genes in worldwide isolates of viral genotypes 1\u20136","volume":"60","author":"Pati\u00f1o-Galindo","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"issue":"1","key":"10.1016\/j.sjbs.2021.12.044_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1208809","article-title":"Exploratory study of oral combination antiviral therapy for hepatitis C","volume":"368","author":"Poordad","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.sjbs.2021.12.044_b0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756283X13515825","article-title":"Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential","volume":"7","author":"Stedman","year":"2014","journal-title":"Therapeut. Adv. Gastroenterol."},{"issue":"10","key":"10.1016\/j.sjbs.2021.12.044_b0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jvh.12168","article-title":"Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3","volume":"20","author":"Tapper","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.sjbs.2021.12.044_b0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/525259","article-title":"Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b","volume":"46","author":"Tu","year":"2008","journal-title":"Clin. Infect. Diseases"},{"issue":"21","key":"10.1016\/j.sjbs.2021.12.044_b0105","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","article-title":"Sofosbuvir and ribavirin in HCV genotypes 2 and 3","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21010779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21010779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:27:15Z","timestamp":1761154035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X21010779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1319562X21010779"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.12.044","relation":{},"ISSN":["1319-562X"],"issn-type":[{"type":"print","value":"1319-562X"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of resistance against direct acting antivirals in chronic HCV patients: A real-world study","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.12.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}